PLYX
Polaryx Therapeutics, Inc.
2.10$
-0.5%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|
| – | – | -11.3% | -20.2% | +68.9% | -9.4% | -35.4% | +237.3% | |
| – | – | -11.3% | -20.2% | +68.9% | -13.6% | -32.3% | +237.3% | |
| – | – | -9.9% | -20.6% | +73.9% | -10.5% | -40.1% | +274.7% | |
| – | – | -9.9% | -20.6% | +73.9% | -10.5% | -40.1% | +274.7% | |
| – | – | -36.0% | +60.0% | +130.4% | +25.4% | +18.6% | -13.9% | |
| – | – | -36.0% | +60.0% | +130.4% | -11.3% | +67.6% | -13.9% | |
| – | – | -23.6% | +187.3% | +213.9% | -5.2% | +80.9% | -19.6% | |
| – | – | -9.7% | -23.7% | +63.3% | -13.9% | -45.5% | +339.7% | |
| – | – | – | – | – | – | – | – | |
| – | +0.0% | +0.0% | +0.0% | +0.0% | -75.0% | -0.3% | +2.2% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.